Tags:
A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology. (2008).
09/27/2018
Cannabinoids for the treatment of dementia. (2009).
09/27/2018

Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease. (2016).

Author(s): IVÁN MANUEL, LAURA LOMBARDERO, FRANK M. LAFERLA, LYDIA GIMÉNEZ-LLORT AND RAFAEL RODRÍGUEZ PUERTAS.

The positive regulation of the galaninnergic and endocannabinoid systems supports the hypothesis of their neuroprotective functions, which are established before clear clinical cognitive symptoms of Alzheimer’s disease appear. View study